For example, if the target is bone growth in elderly men with osteopenia or osteoporosis, but with no overt signs of hypogonadism, an SARM targeting bone and muscle tissue, but with lesser activity on the prostate or testes would be more desirable.
Isibonelo, uma kuhloswe ukukhula kwethambo kumadoda asebekhulile abane-osteopenia noma i-osteoporosis, kodwa bengenayo izibonakaliso ezingaphezu kwe-hypogonadism, i-SARM powder eqondisa amathambo kanye nezicubu zomzimba kodwa uma umsebenzi omncane ku-prostate noma i-testes ingaba yinto efiselekayo.